Medscape Medical News: Will Asundexian Change Secondary Stroke Prevention? (+...)

Medscape Medical News Will Asundexian Change Secondary Stroke Prevention? With the first factor XIa inhibitor now FDA-approved, stroke experts weigh its potential to transform secondary stroke prevention — and the challenges that could limit its adoption. Medscape Medical News, November 11, 2026 https://www.medscape.com/index/list_11861_0